United States securities and exchange commission logo





                            December 21, 2023

       Li He, Esq.
       Partner, Davis Polk & Wardwell LLP
       Genetron Holdings Limited
       1-2/F, Building 11, Zone 1
       No. 8 Life Science Parkway
       Changping District, Beijing, 102206
       People   s Republic of China

                                                        Re: Genetron Holdings
Limited
                                                            Schedule 13E-3
filed November 27, 2023
                                                            Filed by Genetron
Holdings Limited et al.
                                                            File No. 005-92048

       Dear Li He:

              We have reviewed your filing and have the following comments. In
some of our
       comments, we may ask you to provide us with information so we may better
understand your
       disclosure.

               Please respond to these comments by providing the requested
information or advise us as
       soon as possible when you will respond. If you do not believe our
comments apply to your facts
       and circumstances, please tell us why in your response.

                                                        After reviewing your
response to these comments, we may have additional comments.

       Schedule 13E-3 filed November 27, 2023; Preliminary Proxy Statement
filed as Exhibit (a)-(1)

       Background of the Merger, page 20

   1.                                                   We note the references
to the October 2022 Projections and April 2023 Projections. Please
                                                        disclose those
projections and attach as exhibits to the Schedule 13E-3 any board books
                                                        presented by Duff &
Phelps to the Special Committee in addition to the presentation
                                                        already filed as
Exhibit (C)(2).
       Transactions in the Shares and ADSs, page 95

   2.                                                   Please provide
additional detail regarding the shares "purchased" by Mr. Xu during the
                                                        second quarter of 2022
and explain why the price "paid" per share was $0.00.
 Li He, Esq.
Genetron Holdings Limited
December 21, 2023
Page 2
Security Ownership of Certain Beneficial Owners and Management of the Company,
page 96

3.     Please explain the discrepancy between (i) the number of shares reported
as owned in the
       aggregate by the directors and executive officers of the Company and
(ii) the sum of the
       shares individually owned by Messrs. Wang, Yan, and Jiao.
General

4.     Please confirm, if true, that because the required approval threshold
for the merger is two-
       thirds of votes cast (rather than two-thirds of all outstanding shares),
and because the
       Rollover Shareholders collectively own 59.7% of shares entitled to vote,
approval of the
       merger has already, for practical purposes, been "locked up."
5.     Please disclose the Amended and Restated Memorandum of Association and
Articles of
       Association of the Surviving Company.
        We remind you that the filing persons are responsible for the accuracy
and adequacy of
their disclosures, notwithstanding any review, comments, action or absence of
action by the staff.

       Please direct any questions to David Plattner at 202-551-8094.



                                                             Sincerely,
FirstName LastNameLi He, Esq.
                                                             Division of
Corporation Finance
Comapany NameGenetron Holdings Limited
                                                             Office of Mergers
and Acquisitions
December 21, 2023 Page 2
cc:       Xuelin (Steve) Wang, Esq.
FirstName LastName